We research and develop highly complex biological and biosimilar medicines to improve patients’ lives.
Our main goal is to increase patient access to highly complex biological medicines, promoting better health and overall well-being.
Bionovis is a company 100% dedicated to biotechnology and our industrial unit uses cutting-edge technology, adhering to rigorous quality standards to ensure the efficacy and safety of our biological and biosimilar medicines.
We take pride in being part of Brazil`s healthcare transformation.
“By expanding access to highly complex biological and biosimilar medicines, we strive to positively transform patients’ lives and play a leading role in the healthcare sector.”
Bionovis Team
Bionovis researches, develops, manufactures, and markets highly complex biopharmaceuticals to improve the lives of thousands of patients. The company is committed to becoming the leading biopharmaceutical enterprise in Latin America and expanding its global presence.
For more than a decade, we have built partnerships with major global leaders in the pharmaceutical industry and public laboratories, such as Bio-Manguinhos/FIOCRUZ, Fresenius Kabi, Johnson & Johnson, Merck, Samsung Bioepis and Sandoz. We have also established commercialization partnerships in the private sector with INTAS and mAbxience. Through these partnerships, we receive complete technology for producing innovative biopharmaceuticals and biosimilars. We are certified by ANVISA for the production of biological and biosimilar medicines.
Our specialized Bionovis Team is dedicated to delivering innovative, high-quality solutions — motivated by the pride of contributing to Brazil’s healthcare transformation, and improving the well-being and quality of life of its people.
Transform your patients’ lives with our highly complex biological and biosimilar medicines.
Bionovis is a pioneer in the production and commercialization of biological and biosimilar medicines.
Our pursuit of scientific innovations and highly complex medicines aims to build a healthier Brazil — and a healthier world — for everyone.
© 2025 Bionovis. Companhia Brasileira de Biotecnologia Farmacêutica.
